Epidemiology of Musculoskeletal Manifestations in Pediatric Inflammatory Bowel Disease: A Systematic Review

被引:1
|
作者
Ali, Aaisham [1 ]
Schmidt, Melanie [2 ]
Piskin, David [2 ]
Crowley, Eileen [3 ,4 ]
Berard, Roberta [3 ,4 ]
机构
[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[2] Lawson Hlth Res Inst, London, ON, Canada
[3] Western Univ, Childrens Hosp Western Ontario, London Hlth Sci Ctr, Schulich Sch Med & Dent, London, ON, Canada
[4] Childrens Hlth Res Inst, Lawson Hlth Res Inst, London, ON, Canada
关键词
EXTRAINTESTINAL MANIFESTATIONS; ULCERATIVE-COLITIS; ARTHRITIS; CLASSIFICATION; PREVALENCE; CONSENSUS; CHILDREN;
D O I
10.1002/acr2.11431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Pediatric inflammatory bowel disease (p-IBD) is a chronic relapsing gastrointestinal disorder of childhood with long-term morbidity. Several extraintestinal manifestations are described, the most common being joint pain and/or inflammation. However, patient and disease characteristics, treatments, and outcomes of p-IBD-associated musculoskeletal disease are not well established. Our study aims to summarize the recent literature on the epidemiology of musculoskeletal manifestations in p-IBD in the era of biologics. Methods A systematic search of PubMed, Embase, Cochrane Library, Web of Science Core Collection, and Cumulative Index to Nursing and Allied Health Literature databases was performed with relevant keywords. Studies in English published from January 1, 2000, to December 21, 2020, were included. In total, 3893 articles were identified and screened. Study and population characteristics and outcomes of interest were recorded. Risk of bias assessment was performed using the Joanna Briggs Institute Critical Appraisal Tools. Results Thirteen studies were included for full review, which were primarily single-center observational studies with retrospective or cross-sectional designs. The diagnostic criteria and definitions used for musculoskeletal manifestations varied. Musculoskeletal manifestation prevalence ranged from 2% to 35%. Only one study assessed the response of musculoskeletal manifestations to biologics. Risk of bias demonstrated heterogeneity in study quality. Conclusion This is the first systematic review of musculoskeletal manifestations in p-IBD. Analysis was limited because of variability in study design and data-reporting methods. Definitions varied among included studies, with a clear lack in standardization. Our study demonstrates the need for standardized assessment of musculoskeletal manifestations of p-IBD and further research to explore optimal management to advance care for this group of children.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 50 条
  • [31] Dermatologic manifestations in pediatric patients with inflammatory bowel disease
    Afarideh, Mohsen
    Bartoletta, Katherine
    Tollefson, Megha M.
    [J]. PEDIATRIC DERMATOLOGY, 2024, 41 (02) : 234 - 242
  • [32] Clinical and Colonoscopic Manifestations of Pediatric Inflammatory Bowel Disease
    Luo, Y.
    Chen, J.
    [J]. WCPGHAN 3: WORLD CONGRESS OF PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION, 2008, : 97 - 102
  • [33] Dermatologic Manifestations of Inflammatory Bowel Disease: A Review
    Keyal, Uma
    Liu, Yeqiang
    Bhatta, Anil Kumar
    [J]. DISCOVERY MEDICINE, 2018, 25 (139) : 225 - 233
  • [34] Cutaneous manifestations in inflammatory bowel disease (Review)
    Ungureanu, Loredana
    Cosgarea, Rodica
    Alexandru Badea, Mihail
    Florentina Vasilovici, Alina
    Cosgarea, Ioana
    Corina Senila, Simona
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (01) : 31 - 37
  • [35] Systematic Review: The Role of Breastfeeding in the Development of Pediatric Inflammatory Bowel Disease
    Barclay, Andrew R.
    Russell, Richard K.
    Wilson, Michelle L.
    Gilmour, W. Harper
    Satsangi, Jack
    Wilson, David C.
    [J]. JOURNAL OF PEDIATRICS, 2009, 155 (03): : 421 - 426
  • [36] Effectiveness and Safety of Ustekinumab for Pediatric Inflammatory Bowel Disease: A Systematic Review
    Fang, Shengbo
    Zhang, Sixi
    Zhang, Chunyan
    Wang, Libo
    [J]. PEDIATRIC DRUGS, 2023, 25 (05) : 499 - 513
  • [37] A SYSTEMATIC REVIEW OF PSYCHOSOCIAL CORRELATES OF PAIN IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Murphy, Lexa K.
    de la Vega, Rocio
    Levy, Rona L.
    Palermo, Tonya M.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S553 - S553
  • [38] Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease
    Murphy, Lexa K.
    de la Vega, Rocio
    Kohut, Sara Ahola
    Kawamura, Joy S.
    Levy, Rona L.
    Palermo, Tonya M.
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (05) : 697 - 710
  • [39] Effectiveness and Safety of Ustekinumab for Pediatric Inflammatory Bowel Disease: A Systematic Review
    Shengbo Fang
    Sixi Zhang
    Chunyan Zhang
    Libo Wang
    [J]. Pediatric Drugs, 2023, 25 : 499 - 513
  • [40] Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management
    Larsen, Signe
    Bendtzen, Klaus
    Nielsen, Ole Haagen
    [J]. ANNALS OF MEDICINE, 2010, 42 (02) : 97 - 114